Program Purpose Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CE and MOC-accredited programs. This program is presented by leading and local authorities in tumor immunology and cancer immunotherapy
12-04-2019 | 15:30 - 20:20 CT Nashville TN
2015 Advances in Cancer Immunotherapy™ - Nashville, TN October 2, 2015 Vanderbilt Student Life Center Nashville, TN Program Organizers Igor Puzanov, MD, MSCI, FACP – Vanderbilt University Anil Shanker, PhD – Meharry Medical College/Vanderbilt University Jeffrey A. Sosman, MD – Vanderbilt University Program Summary From the Society for Immunotherapy of Cancer (SITC), these enduring materials from the 2015 Advances in Cancer Immunotherapy™ - Nashville, TN provides an understanding of basic immunology principles in the clinical application and management of cancer immunotherapy and discuss emerging drugs and concepts in the cancer immunotherapy field. Presented by leading authorities in tumor immunology and cancer immunotherapy, this program facilitated an understanding of: The underlying principles of tumor immunology and immunotherapy The clinical indications for cancer immunotherapy and appropriate selection of patients Patient management The therapeutic effectiveness of immunotherapy to ultimately improve patient outcomes
15 attachments
Presentation slides and video from the 2019 Advances in Cancer Immunotherapy TM - Nashville, TN, held on December 4, 2019 are available here
21 attachments
Closing Remarks Program Purpose Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these programs will facilitate understanding of: The rationale for common approaches to immunotherapy The appropriate clinical management of common side effects of immunotherapy agents Implementing appropriate cancer immunotherapy treatments for skin, lung, genitourinary, head and neck, hematologic and/or additional solid tumor cancers in clinical practice Overcoming operational and financial barriers to integrating cancer immunotherapy into their practice setting Appropriate implementation of cancer care counsel in the clinical setting Attendees will also have an opportunity for connecting with regional experts in the immunotherapy field at the live event, through four quarterly webinars, and indefinitely through a dedicated online community forum
Johnson, MD – Sarah Cannon Research Institute 7:05 – 7:45 p.m. Practical Barriers in Cancer Immunotherapy Treatment 7:45 – 8:15 p.m
EST Practical Barriers in Cancer Immunotherapy Treatment Akiko Shimamota, PhD – Meharry Medical College 8:40 – 9:15 p.m
Advances in Cancer Immunotherapy™ is a CME- and CE-certified program for clinical oncologists, registered nurses, pharmacists and others involved in treating cancer patients with immunotherapy to learn basic immunology principles and the mechanisms and clinical applications of immunotherapy. Advances in Cancer Immunotherapy™ (ACI) Series ACI programs are certified for CME, CNE, CPE, and MOC credits.
The Advances in Cancer Immunotherapy™ (ACI) Committee oversees the planning and implementation of SITC’s regional introductory, CME-, CNE-, CPE- and MOC-certified programs created for the entire clinical cancer care team. The committee provides expert guidance to the appropriate audiences and timely content relevant to advancing patient care using FDA-approved immunotherapies
Logan, MD – Indiana University Simon Cancer Center This program has already taken place, to find information on upcoming programs, please check here. Program Purpose Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE- and CNE-accredited programs. This program is presented by leading and local authorities in tumor immunology and cancer immunotherapy . ACI-Indianapolis Program Registration Advance online registration for the Advances in Cancer Immunotherapy™ education program in Indianapolis, IN is now closed
10-25-2018 | 16:30 - 21:00 ET
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us